Global Raltegravir Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 21454
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 114
  • list Pharmaceuticals and Healthcare

Raltegravir (RAL), sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS.

The global Raltegravir market is valued at xx million US$ In 2020 and will reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2020-2026. The objectives of this study are to define, segment, and project the size of the Raltegravir market based on company, product type, end user and key regions.

This report studies the global market size of Raltegravir in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Raltegravir in these regions.

This research report categorizes the global Raltegravir market by top players/brands, region, type and end user. This report also studies the global Raltegravir market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Merck & Co.


Market size by Product


Oral powder

Market size by End User


Drug store


Market size by Region

North America

United States







South Korea















Central & South America


Rest of Central & South America

Middle East & Africa

GCC Countries



South Africa

The study objectives of this report are:

To study and analyze the global Raltegravir market size (value & volume) by company, key regions, products and end user, breakdown data from 2015 to 2019, and forecast to 2026.

To understand the structure of Raltegravir market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Raltegravir companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Raltegravir submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Raltegravir are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Raltegravir market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Study Coverage

1.1 Raltegravir Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Raltegravir Market Size Growth Rate by Product

1.4.2 Tablet

1.4.3 Oral powder

1.5 Market by End User

1.5.1 Global Raltegravir Market Size Growth Rate by End User

1.5.2 Hospital

1.5.3 Drug store

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Raltegravir Market Size

2.1.1 Global Raltegravir Revenue 2015-2026

2.1.2 Global Raltegravir Sales 2015-2026

2.2 Raltegravir Growth Rate by Regions

2.2.1 Global Raltegravir Sales by Regions

2.2.2 Global Raltegravir Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Raltegravir Sales by Manufacturers

3.1.1 Raltegravir Sales by Manufacturers

3.1.2 Raltegravir Sales Market Share by Manufacturers

3.1.3 Global Raltegravir Market Concentration Ratio (CR5 and HHI)

3.2 Raltegravir Revenue by Manufacturers

3.2.1 Raltegravir Revenue by Manufacturers (2015-2020)

3.2.2 Raltegravir Revenue Share by Manufacturers (2015-2020)

3.3 Raltegravir Price by Manufacturers

3.4 Raltegravir Manufacturing Base Distribution, Product Types

3.4.1 Raltegravir Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Raltegravir Product Type

3.4.3 Date of International Manufacturers Enter into Raltegravir Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Raltegravir Sales by Product

4.2 Global Raltegravir Revenue by Product

4.3 Raltegravir Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Raltegravir Breakdown Data by End User

6 North America

6.1 North America Raltegravir by Countries

6.1.1 North America Raltegravir Sales by Countries

6.1.2 North America Raltegravir Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Raltegravir by Product

6.3 North America Raltegravir by End User

7 Europe

7.1 Europe Raltegravir by Countries

7.1.1 Europe Raltegravir Sales by Countries

7.1.2 Europe Raltegravir Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Raltegravir by Product

7.3 Europe Raltegravir by End User

8 Asia Pacific

8.1 Asia Pacific Raltegravir by Countries

8.1.1 Asia Pacific Raltegravir Sales by Countries

8.1.2 Asia Pacific Raltegravir Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Raltegravir by Product

8.3 Asia Pacific Raltegravir by End User

9 Central & South America

9.1 Central & South America Raltegravir by Countries

9.1.1 Central & South America Raltegravir Sales by Countries

9.1.2 Central & South America Raltegravir Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Raltegravir by Product

9.3 Central & South America Raltegravir by End User

10 Middle East and Africa

10.1 Middle East and Africa Raltegravir by Countries

10.1.1 Middle East and Africa Raltegravir Sales by Countries

10.1.2 Middle East and Africa Raltegravir Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Raltegravir by Product

10.3 Middle East and Africa Raltegravir by End User

11 Company Profiles

11.1 Merck & Co.

11.1.1 Merck & Co. Company Details

11.1.2 Company Business Overview

11.1.3 Merck & Co. Raltegravir Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Merck & Co. Raltegravir Products Offered

11.1.5 Merck & Co. Recent Development

11.2 Hetero

11.2.1 Hetero Company Details

11.2.2 Company Business Overview

11.2.3 Hetero Raltegravir Sales, Revenue and Gross Margin (2015-2020)

11.2.4 Hetero Raltegravir Products Offered

11.2.5 Hetero Recent Development

12 Future Forecast

12.1 Raltegravir Market Forecast by Regions

12.1.1 Global Raltegravir Sales Forecast by Regions 2020-2026

12.1.2 Global Raltegravir Revenue Forecast by Regions 2020-2026

12.2 Raltegravir Market Forecast by Product

12.2.1 Global Raltegravir Sales Forecast by Product 2020-2026

12.2.2 Global Raltegravir Revenue Forecast by Product 2020-2026

12.3 Raltegravir Market Forecast by End User

12.4 North America Raltegravir Forecast

12.5 Europe Raltegravir Forecast

12.6 Asia Pacific Raltegravir Forecast

12.7 Central & South America Raltegravir Forecast

12.8 Middle East and Africa Raltegravir Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Raltegravir Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables and Figures

Figure Raltegravir Product Picture

Table Raltegravir Market Segments

Table Key Manufacturers Raltegravir Covered

Table Global Raltegravir Marke